Rescue of α-synuclein cytotoxicity by insulin-like growth factors (original) (raw)

alpha -Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells. ABOLISHMENT BY 6-HYDROXYDOPAMINE AND IMPLICATION FOR PARKINSON'S DISEASE

ROBERTO FERREIRA

Journal of Biological Chemistry, 2002

View PDFchevron_right

Drug Targets from Genetics: Alpha-Synuclein

Karin Danzer

CNS & Neurological Disorders - Drug Targets, 2011

View PDFchevron_right

The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells

Hamid Yaqoob Qureshi

Journal of Neurochemistry, 2009

View PDFchevron_right

lpzgc synuclein biochem_11.pdf

Claudio Zannoni

View PDFchevron_right

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Michael Schlossmacher

npj Parkinson's Disease

View PDFchevron_right

-Synuclein Displays an Antiapoptotic p53-dependent Phenotype and Protects Neurons from 6-Hydroxydopamine-induced Caspase 3 Activation: CROSS-TALK WITH -SYNUCLEIN AND IMPLICATION FOR PARKINSON'S DISEASE

ROBERTO FERREIRA

Journal of Biological Chemistry, 2003

View PDFchevron_right

Genetic Analysis of Families with Parkinson Disease that Carry the Ala53Thr Mutation in the Gene Encoding α-Synuclein

A. Athanassiadou

The American Journal of Human Genetics, 1999

View PDFchevron_right

Can α-synuclein be targeted in novel therapies for Parkinson’s disease?

Patrik Brundin

Expert Review of Neurotherapeutics, 2011

View PDFchevron_right

Synucleins and their relationship to Parkinson?s disease

Oliver von Bohlen und Halbach

Cell and Tissue Research, 2004

View PDFchevron_right

Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration HISTORIC PERSPECTIVE OF THE DISCOVERY OF ALPHA-SYNUCLEIN

Diana Lázaro

View PDFchevron_right

α-Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells

cristine Alves da Costa

Journal of Biological Chemistry, 2002

View PDFchevron_right

Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease

Zbigniew Wszolek

Parkinsonism & Related Disorders, 2013

View PDFchevron_right

Defining α-synuclein species responsible for Parkinson disease phenotypes in mice

Drake Thrasher

Journal of Biological Chemistry

View PDFchevron_right

Poster Session BP07: Neurodegenerative Diseases

farah jayman

Journal of Neurochemistry, 2008

View PDFchevron_right

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

A. Athanassiadou

Science, 1997

View PDFchevron_right

Disorders with Synuclein Pathology and Parkinsonism

Laura L Kilarski

View PDFchevron_right

Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson’s disease pathogenesis

Mauro Fasano

FEBS Journal, 2010

View PDFchevron_right

Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein

Anthony Adame, Klodjan Stafa, Kori Kosberg

Neuron, 2015

View PDFchevron_right

Aggregation promoting C-terminal truncation of -synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

Juan Troncoso

Proceedings of the National Academy of Sciences, 2005

View PDFchevron_right

Parkinson's disease and α-synuclein expression

Kat Gwinn

Movement Disorders, 2011

View PDFchevron_right

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models

Javiera Arcos

View PDFchevron_right

Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells

Marc Hurlbert

Brain Research, 2000

View PDFchevron_right

α-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease

Tziona Ben-Gedalya

PLoS ONE, 2011

View PDFchevron_right

Role of sporadic Parkinson disease associated mutations A18T and A29S in enhanced alpha synuclein fibrillation and cytotoxicity

roshan love kumar

ACS chemical neuroscience, 2017

View PDFchevron_right

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

Kat Gwinn

2011

View PDFchevron_right

The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition

Rose Sharon

Journal of Biological Chemistry, 2010

View PDFchevron_right

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease

Denise Barbut

Frontiers in Cell and Developmental Biology, 2021

View PDFchevron_right

Synoretin—A New Protein Belonging to the Synuclein Family

Andrei Surguchov

Molecular and Cellular Neuroscience, 1999

View PDFchevron_right

α-Synuclein in Parkinson’s disease: causal or bystander?

Wolfgang Jost

Journal of Neural Transmission, 2019

View PDFchevron_right